Results 1 to 10 of about 20,473 (161)
Neosinus and Valve Thrombosis After Transcatheter Aortic Valve Replacement [PDF]
Transcatheter aortic valve replacement is regarded as an effective intervention for patients with aortic stenosis and has now been extended to low‐risk populations.
Nan Chen, Yu Mao, Hui‐Ping Zhang
doaj +2 more sources
Transcatheter aortic valve replacement
Anneke Damberg, Carina Benstoem, Ruediger Autschbach, Andreas GoetzenichDepartment of Cardiovascular and Thoracic Surgery, University Clinic RWTH Aachen, Aachen, GermanyAbstract: The standard treatment for symptomatic severe aortic valve stenosis is ...
Damberg A +3 more
doaj +3 more sources
Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Disease
BACKGROUND Limited information exists describing the results of transcatheter aortic valve (TAV) replacement in patients with bicuspid aortic valve (BAV) disease (TAV-in-BAV). OBJECTIVES This study sought to evaluate clinical outcomes of a large cohort of patients undergoing TAV-in-BAV.
Thomas Modine +2 more
exaly +6 more sources
Transcatheter Aortic Valve Replacement for Aortic Insufficiency. [PDF]
Transcatheter aortic valve replacement (TAVR) has developed into a viable treatment for aortic regurgitation (AR), particularly in high-risk or elderly patients unable to undergo surgery. Early generation devices encountered significant challenges, including high mortality rates, residual paravalvular leaks, and complications such as valve embolisation.
Amara M, Feld Y.
europepmc +3 more sources
Outcomes of Transcatheter Aortic Valve Replacement in Mixed Aortic Valve Disease: A Comparison Between Bicuspid and Tricuspid Valves [PDF]
Background The impact of aortic valve morphology on outcomes after transcatheter aortic valve replacement in patients with mixed aortic valve disease, characterized by the coexistence of aortic stenosis and regurgitation, remains poorly defined.
Yu Tang +20 more
doaj +2 more sources
Transcatheter Aortic Valve Replacement [PDF]
Aortic stenosis is the most frequent valvular heart disease in the USA, and aortic valve replacement remains the only definitive treatment. For patients who cannot have surgery or who are at an increased risk for surgical aortic valve replacement (SAVR), transcatheter aortic valve replacement (TAVR) has become an established treatment option.
John K, Forrest +2 more
openaire +5 more sources
Transcatheter Aortic-Valve Replacement [PDF]
Case History: A 77-year-old man presents with fatigue and shortness of breath with minimal exertion. He is brought into the examination room in a wheelchair due to shortness of breath with ambulation. He has a history of hypertension, diabetes mellitus, and coronary artery disease with prior stent to left anterior descending artery.
Rita F, Redberg, Sanket S, Dhruva
openaire +4 more sources
Objectives: Bicuspid aortic valves have been excluded from randomized trials comparing transcatheter aortic valve replacement with surgical aortic valve replacement.
Yosuke Sakurai, MD +7 more
doaj +1 more source
Challenging Anatomies for TAVR—Bicuspid and Beyond
Transcatheter aortic valve replacement has emerged as the standard treatment for the majority of patients with symptomatic aortic stenosis. As transcatheter aortic valve replacement expands to patients across all risk groups, optimal patient selection ...
Mohammed Saad +4 more
doaj +1 more source
Objective: With expanding eligibility criteria, transcatheter aortic valve replacement is being performed on patients with longer life expectancy, and subsequent procedures after index transcatheter aortic valve replacement are inevitable.
Paige Newell, MD +10 more
doaj +1 more source

